Skip to main content

Pneumoccal Vaccine

·73 words·1 min

NEJM -- Decline in Invasive Pneumococcal Disease after the Introduction of Protein-Polysaccharide Conjugate Vaccine

The largest decline was in children under two years of age. In this group, the rate of disease was 69 percent lower in 2001 than the base-line rate (59.0 cases per 100,000 vs. 188.0 per 100,000, P<0.001)

Pneumoccal vaccine works.  But invasive disease remains relatively rare.  When parents ask me if I think it's essential, I can't say yes.